CAH / Cardinal Health Is A Great Bargain Buy, Here's Why

Cardinal Health's (CAH) first-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance. more_horizontal

Cardinal Health (CAH) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.40 per share. This compares to e more_horizontal

Shares of Cardinal Health Inc. CAH, +0.21% climbed 1.3% into record territory in premarket trading Friday, after the drug distributor reported fiscal more_horizontal

Cardinal Health's (CAH) first-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical segment. more_horizontal

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe more_horizontal

Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of pr more_horizontal

As uncertainty seems to dominate, it might be time to look for stocks to own during a downturn. For 10 straight months, investors enjoyed a strong com more_horizontal

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. more_horizontal